LAUREN DUVALL: Open Payments
NPI 1952801078 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,542 in 90 payments from 18 companies in 2025. Trend: 2023 $371 · 2024 $2,118 · 2025 $1,542
Food & beverage: $1,542
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 10 | $190 |
| Alkermes, Inc. | 14 | $177 |
| ABBVIE INC. | 14 | $176 |
| Axsome Therapeutics, Inc. | 3 | $172 |
| Lundbeck LLC | 11 | $143 |
| Janssen Pharmaceuticals, Inc | 6 | $118 |
| Teva Pharmaceuticals USA, Inc. | 5 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| E.R. Squibb & Sons, L.L.C. | 4 | $68 |
| Luye Pharma (USA) Ltd. | 3 | $63 |
Products named: INGREZZA, VRAYLAR, REXULTI, Auvelity, ARISTADA, INVEGA SUSTENNA, CAPLYTA, COBENFY.
Industry payments across OH — which companies pay providers there.
